Zauatbayeva, G. , Syzdykova , L., Keyer , V. , Shustov , A., Abilmagzhanov , A. and Zhurynov , M. 2022. NUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS. Eurasian Journal of Applied Biotechnology. 2 (Jul. 2022), 44–53. DOI:https://doi.org/10.11134/btp.2.2022.7.